Chemomab Therapeutics Ltd. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Chemomab Therapeutics Ltd. (CMMB) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-23
- Chemomab Therapeutics Ltd. right-of-use asset obtained in exchange for operating lease liability for fiscal 2020 was $233.00K, a 219.18% increase from fiscal 2019.
- Chemomab Therapeutics Ltd. right-of-use asset obtained in exchange for operating lease liability for fiscal 2019 was $73.00K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-23 |
| 2024-12-31 | $0.00 20-F · filed 2026-03-23 |
| 2023-12-31 | $392.00K 20-F · filed 2026-03-23 |
| 2022-12-31 | $17.00K 20-F · filed 2025-04-04 |
| 2021-12-31 | $345.00K 20-F · filed 2024-03-28 |
| 2020-12-31 | $233.00K 10-K · filed 2022-03-30 |
| 2019-12-31 | $73.00K 10-K · filed 2020-03-17 |